• DOI:10.1016/S0168-8278(01)00080-0
Corpus ID: 41195094

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

@article{Marzano2001PreventionOH,
  title={Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.},
  author={A. Marzano and M. Salizzoni and W. Debernardi-Venon and A. Smedile and A. Franchello and A. Ciancio and E. Gentilcore and P. Piantino and A. Barbui and E. David and F. Negro and M. Rizzetto},
  journal={Journal of hepatology},
  year={2001},
  volume={34 6},
  pages={
          903-10
        }
}

• A. Marzano, M. Salizzoni, +9 authors M. Rizzetto
• Published 2001
• Medicine
• Journal of hepatology

BACKGROUND/AIMS Treatment with hepatitis B virus immune globulins (HBIG) or lamivudine has reduced the rate of hepatitis B recurrence after liver transplantation to approximately 50%. METHODS To further decrease hepatitis B recurrence, 33 hepatitis B virus (HBV)-related cirrhotic patients were treated with lamivudine before liver transplantation and with lamivudine together with low-dose HBIG (46 500 IU the first month followed by 5,000 lU/monthly) after surgery. RESULTS While on lamivudine… Expand